Managers

Longitude, Column Group, Altos top late-decade venture portfolio at CalPERS

Another unicorn goes poof! Feds charge Mozido founder with fraud

Cloud Apps Capital Partners raises $66.7 mln for second fund

Cloud Apps Capital Partners has raised $66.7 million toward a $100 million second early stage fund, according to a filing with the SEC.

Sinovation Ventures to raise $500 mln for fourth fund

Sinovation Ventures has set a $500 million target for its fourth fund, according to an SEC filing. The San Francisco-based early-stage venture firm focuses on Chinese and U.S. tech startups.

Alzheon sets IPO pricing terms

Framingham, Massachusetts-based Alzheon Inc, a biopharmaceutical company focused on brain health, memory and aging, has priced 5 million shares of its IPO at between $13 and $15 per share. The stock will trade on the NASDAQ under the ticker symbol "ALZH." Citigroup Global Markets Inc. and Piper Jaffray & Co. are the lead underwriters. Alzheon's backers include Ally Bridge Group.

Macrolide Pharmaceuticals snags $20 mln

Watertown, Massachusetts-based Macrolide Pharmaceuticals, a developer of antibiotics for for drug-resistant, hospital-acquired infections, has raised $20 million in financing. The lead investors were Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One.

Get your 2018 employee compensation data here!

Phil Black of True Ventures on crypto deals and being named Venture Firm of the Year

Unitus raises $12.9 mln for second seed fund

The Unitus Seed Fund has raised $12.9 million for a second seed fund, according to a filing with the SEC.

Venture spies new avenues to liquidity